Tom Shea

Chief Financial Officer

Tom Shea joined Albireo in July 2016 as Chief Financial Officer. Previously, he served as Executive Vice President and Chief Financial Officer of Epirus Biopharmaceuticals, a multinational biosimilar company. Prior to Epirus, Tom served as the Chief Financial Officer of multiple biopharmaceutical companies, including Tolerx and sister companies Euthymics, Neurovance, and EBI Life Sciences. Formerly, he was Chief Financial Officer at Cubist Pharmaceuticals (acquired by Merck) where he was one of its initial employees and served for 10 years, playing a leadership role in Cubist’s successful initial public offering.

Team members

Ron Cooper

President and Chief Executive Officer

Martha (Muffy) Carter

Chief Regulatory Officer

Per-Göran Gillberg, Ph.D., Prof.

Vice President, Development and Co-Founder

Jan Mattsson, Ph.D.

Chief Operating Officer and Co-Founder

Tom Shea

Chief Financial Officer

Paresh Soni, M.D., Ph.D.

Chief Medical Officer

Kristina Torfgård, Ph.D.

Vice President, Global Project Head

Pete Zorn

Chief Corporate Officer and General Counsel